Bioeutectics
PrivateLast Round
Seed
Jan 23, 2024
Total Funding Raised
$2.82M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Bioeutectics operates in Energy & Sustainability and is based in Tulsa, Oklahoma. Its latest recorded funding round was a Seed round in January 2024.
Bioeutectics is a biotechnology company developing natural and sustainable eutectic solvents to replace petrochemicals in industrial processes.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty, Clean Manufacturing, Circular Economy
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioeutectics Comparables
Compare Bioeutectics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NADES Design | 79% | |
| Minafin Group | 77% | |
| Shrieve Chemical Company | 73% |
For institutional investors. Book with your work email.
Bioeutectics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 23, 2024 | ||||
| Pre Seed | Dec 22, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bioeutectics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GRIDX | Seed, Pre Seed |
| Fen Ventures | Seed |
| IndieBio | Seed |
| Atento Capital | Seed |
| Syensqo Ventures | Seed |
| SOSV | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Grew 21% QoQ, from 14 to 17 employees.
- Aug 2, 2026
Grew 29% QoQ from 14 to 18 employees.
For institutional investors. Book with your work email.
Bioeutectics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bioeutectics's valuation, stock price, and market status.
Is Bioeutectics a public or private company?
Bioeutectics is a private company.
What is the current stock price of Bioeutectics?
Bioeutectics is a private company, so its shares have no public market price. Caplight tracks Bioeutectics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bioeutectics worth (valuation)?
Valuation information for Bioeutectics is not publicly available.
Can I buy Bioeutectics stock?
Bioeutectics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bioeutectics's last funding round?
Bioeutectics's most recent funding round was Seed on January 23, 2024.
Who are the main investors in Bioeutectics?
Key investors in Bioeutectics include Fen Ventures, Atento Capital, SOSV.
Will Bioeutectics IPO soon?
No public IPO plans have been announced for Bioeutectics.
How can I track Bioeutectics secondary market activity?
Caplight tracks bids, offers, and trades in Bioeutectics's shares on secondary markets.